| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 29,258 | 26,900 | 22,891 | | Cost of Revenue | 7,686 | 7,768 | 6,958 | | | Gross Profit | 21,572 | 19,132 | 15,933 | | | Operating Expenses | | Research Development | 3,305 | 2,342 | 2,290 | | Selling General and Administrative | 24,092 | 19,400 | 16,810 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,825) | (2,610) | (3,167) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 471 | 773 | 858 | | Earnings Before Interest And Taxes | (5,354) | (1,837) | (2,309) | | Interest Expense | 9 | 17 | 15 | | Income Before Tax | (5,363) | (1,854) | (2,324) | | Income Tax Expense | 129 |
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (5,492) | (1,854) | (2,324) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,492) | (1,854) | (2,324) | | Preferred Stock And Other Adjustments | (578) | (557) | (525) | | | Net Income Applicable To Common Shares | ($6,070) | ($2,411) | ($2,849) |
|
0.12% Nasdaq 
0.33%
Income Statement
